Abeona Therapeutics (NASDAQ:ABEO) will reveal new research findings at the upcoming annual meeting of the American Society of Gene and Cell Therapy.

As quoted in the press release:
Abeona’s collaborators will present two oral and one poster presentation during the conference. These presentations will detail data from clinical and research programs utilizing gene therapy as a potential treatment for patients with the lysosomal storage disorders Sanfilippo syndrome and Batten Disease, and the Company’s next generation AAV AIM™ Vector platform.  Details of the presentations and poster are listed below.

Click here to read the full press release.

Source: globenewswire.com